Stay updated on Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial

Sign up to get notified when there's something new on the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.2 to version 2.16.3.
    Difference
    0.3%
    Check dated 2025-06-13T00:56:39.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.3%
    Check dated 2025-06-05T21:01:14.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    6%
    Check dated 2025-05-29T15:55:11.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-05-01T03:25:36.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.
    Difference
    1%
    Check dated 2025-04-16T14:22:24.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.3%
    Check dated 2025-04-09T09:11:59.000Z thumbnail image

Stay in the know with updates to Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Venetoclax and Lintuzumab-Ac225 in AML Patients Clinical Trial page.